Serial biopsy of the prostate may increase histologic inflammation in the gland among prostate cancer (PCa) patients being managed with active surveillance, but this increase does not appear to be ...
GE HealthCare Technologies Inc. GEHC recently announced the launch of the Prostate Volume Assist (PVA) urology-based artificial intelligence (AI) software feature. This AI-powered software function ...
For more than 80 years, men have been told that testosterone fuels prostate cancer. But a more nuanced picture has emerged ...
A phase II study of IV gemcitabine (G) and oral capecitabine (C) in patients (pts) with advanced renal cell cancer (RCC): Results of Southwest Oncology Group study 0312 No significant financial ...
Prostate Volume Assist (PVA) is the company’s proprietary urology-based artificial intelligence (AI) software feature designed to automate the manual process for generating prostate volume ...
During September’s Prostate Cancer Awareness Month, MidLantic Urology is reminding men of a critical point. It's 0.75. If your PSA increases by 0.75 in 1 year, it could be prostate cancer, and it’s ...
In a recent study published in the journal Prostate Cancer and Prostatic Diseases, researchers investigated the potential associations between human papillomavirus (HPV) infections and prostate ...
Data on whether 5-ARIs increase the risk of prostate cancer-specific mortality have been mixed. Use of 5-alpha-reductase inhibitors (5-ARIs) does not increase the risk of dying from prostate cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results